TrueWealth Advisors LLC Has $1.39 Million Stock Holdings in Globe Life Inc. (NYSE:GL)

TrueWealth Advisors LLC raised its holdings in Globe Life Inc. (NYSE:GLFree Report) by 1.3% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 13,141 shares of the company’s stock after acquiring an additional 170 shares during the quarter. TrueWealth Advisors LLC’s holdings in Globe Life were worth $1,392,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in GL. Vanguard Group Inc. raised its position in shares of Globe Life by 3.9% in the first quarter. Vanguard Group Inc. now owns 11,255,091 shares of the company’s stock valued at $1,309,755,000 after purchasing an additional 425,993 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. raised its position in shares of Globe Life by 7.5% in the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 101,607 shares of the company’s stock valued at $11,824,000 after purchasing an additional 7,100 shares during the period. Savant Capital LLC raised its position in shares of Globe Life by 951.5% in the second quarter. Savant Capital LLC now owns 75,214 shares of the company’s stock valued at $6,189,000 after purchasing an additional 68,061 shares during the period. Achmea Investment Management B.V. raised its position in shares of Globe Life by 151.4% in the second quarter. Achmea Investment Management B.V. now owns 29,684 shares of the company’s stock valued at $2,443,000 after purchasing an additional 17,878 shares during the period. Finally, Bessemer Group Inc. raised its position in shares of Globe Life by 308.5% in the first quarter. Bessemer Group Inc. now owns 11,827 shares of the company’s stock valued at $1,377,000 after purchasing an additional 8,932 shares during the period. 81.61% of the stock is currently owned by institutional investors and hedge funds.

Globe Life Stock Performance

GL traded down $1.58 during trading on Friday, reaching $104.02. 580,778 shares of the company’s stock were exchanged, compared to its average volume of 595,983. Globe Life Inc. has a fifty-two week low of $38.95 and a fifty-two week high of $132.00. The company has a quick ratio of 0.05, a current ratio of 0.05 and a debt-to-equity ratio of 0.31. The business has a 50 day moving average price of $106.10 and a 200 day moving average price of $91.94. The company has a market capitalization of $9.34 billion, a P/E ratio of 8.80 and a beta of 0.81.

Globe Life (NYSE:GLGet Free Report) last posted its quarterly earnings results on Wednesday, October 23rd. The company reported $3.49 earnings per share for the quarter, topping analysts’ consensus estimates of $3.06 by $0.43. Globe Life had a net margin of 19.04% and a return on equity of 22.58%. The firm had revenue of $1.46 billion for the quarter, compared to the consensus estimate of $1.46 billion. During the same quarter in the previous year, the company earned $2.71 earnings per share. The business’s revenue was up 5.1% compared to the same quarter last year. As a group, analysts predict that Globe Life Inc. will post 12.32 earnings per share for the current fiscal year.

Globe Life Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, November 1st. Stockholders of record on Friday, October 4th were paid a $0.24 dividend. The ex-dividend date was Friday, October 4th. This represents a $0.96 annualized dividend and a dividend yield of 0.92%. Globe Life’s dividend payout ratio is presently 8.12%.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on GL. TD Cowen began coverage on shares of Globe Life in a research report on Wednesday, October 9th. They issued a “buy” rating and a $150.00 price target on the stock. Wells Fargo & Company lifted their price target on shares of Globe Life from $108.00 to $117.00 and gave the company an “overweight” rating in a research report on Thursday, October 10th. Morgan Stanley boosted their target price on shares of Globe Life from $110.00 to $120.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 24th. Keefe, Bruyette & Woods boosted their target price on shares of Globe Life from $120.00 to $125.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 29th. Finally, Raymond James boosted their target price on shares of Globe Life from $160.00 to $188.00 and gave the stock a “strong-buy” rating in a research report on Tuesday, October 15th. Five research analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, Globe Life has a consensus rating of “Moderate Buy” and a consensus price target of $124.50.

View Our Latest Stock Report on Globe Life

About Globe Life

(Free Report)

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.

Read More

Want to see what other hedge funds are holding GL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Globe Life Inc. (NYSE:GLFree Report).

Institutional Ownership by Quarter for Globe Life (NYSE:GL)

Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.